Which antidepressants flick the switch?

References

• Zornberg G L, Pope H G. Treatment of depression in bipolar disorder: new directions for research. Journal of Clinical Psychiatry 1993; 13: 397–408
   Google Scholar
• Sachs G S. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. Journal of Clinical Psychiatry 1996; 16(Suppl. 1)32S–47S
   Google Scholar
• Kalin N H. Management of the depressive component of bipolar disorder. Depression and Anxiety 1996/1997; 4: 190–198
   PubMedGoogle Scholar
• Sachs G S, Koslow C L, Ghaemia S N. The treatment of bipolar depression. Bipolar Disorders 2000; 2: 256–260
   PubMed Web of Science ®Google Scholar
• Moller H J, Grunze H. ave some guidelines for treatment of acute bipolar depression gone too far in the restriction of antidepressants?. European Archives of Psychiatry and Clinical Neuroscience 2000; 250: 57–68
   PubMed Web of Science ®Google Scholar
• Wehr T A, Goodwin F K. Can antidepressants cause mania and worsen the course of affective illness?. American Journal of Psychiatry 1987; 144: 1403–1411
   PubMed Web of Science ®Google Scholar
• Angst J. Switch from depression to mania –a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140–154
   PubMed Web of Science ®Google Scholar
• Lewis J L, Winokur G. The induction of mania: a natural history study with controls. Archive of General Psychiatry 1982; 39: 303–305
   PubMed Web of Science ®Google Scholar
• Himmelhoch J M, Thase M E, Mallinger A G, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry 1991; 148: 910–916
   PubMed Web of Science ®Google Scholar
• Kupfer D J, Carpenter L L, Frank E. Possible role of antidepressant in precipitating mania and hypomania in recurrent depression. American Journal of Psychiatry 1988; 145: 804–808
   PubMed Web of Science ®Google Scholar
• Bottlender R, Rudolf D, Strauss A, Moller H J. Antidepressantassociated maniform states in acute treatment of patients with bipolar-I depression. European Archives of Psychiatry and Clinical Neuroscience 1998; 248: 296–300
   PubMed Web of Science ®Google Scholar
• Roulillon F, Gorwood P. The use of lithium to augment antidepressant medication. Journal of Clinical Psychiatry 1998; 59(Suppl. 5)32–39
   Google Scholar
• Boerlin H L, Gitlin M J, Zoelnner A A, Hammen C I. Bipolar depression and antidepressant-induced mania: a naturalistic study. Journal of Clinical Psychiatry 1998; 59: 374–379
   PubMed Web of Science ®Google Scholar
• Fogelson D L, Bystritsky A, Pasnau R. Bupropion in the treatment of bipolar disorders: the same old story?. Journal of Clinical Psychiatry 1992; 53: 443–446
   PubMed Web of Science ®Google Scholar
• Bryois C, Ferrero F. Mania induced by citalopram. Archives of General Psychiatry 1994; 51: 664–665
   PubMed Web of Science ®Google Scholar
• Lebegue B. Mania precipitated by fluoxetine. American Journal of Psychiatry 1987; 144: 1620
   PubMed Web of Science ®Google Scholar
• Burrai C, Bocchetta A, del Zompo M. Mania and fluoxamine. American Journal of Psychiatry 1991; 148: 1263–1264
   PubMed Web of Science ®Google Scholar
• Soutullo C A, McElroy S L, Keck P E. Hypomania associated with mirtazapine augmentation of sertraline. Journal of Clinical Psychiatry 1998; 59: 320
   PubMed Web of Science ®Google Scholar
• Silverstone T. Moclobemide vs. imipramine in bipolar depression: a multicentre double-bind clinical trial. Acta Psychiatrica Scandinavica 2001; 104: 104–109
   PubMed Web of Science ®Google Scholar
• Baldassano C F, Sachs G S, Stoll A L, Lafer B, Truman C J. Paroxetine for bipolar depression: outcome in patients failing prior antidepressant trials. Depression 1995; 3: 182–186
   Google Scholar
• Laporta M, Chouinard G, Goldbloom D, Beauclair L. Hypomania induced by sertraline, a new serotonin reuptake inhibitor. American Journal of Psychiatry 1987; 144: 1513–1514
   PubMed Web of Science ®Google Scholar
• Knobler H Y, Itzchaky S, Emanuel D, Mester R, Maizel S. Trazodone-induced mania. British Journal of Psychiatry 1986; 149: 787–789
   PubMed Web of Science ®Google Scholar
• Wilson R, Jenkins P. Suspected complication of treatment with venlafaxine. Journal of Clinical Psychopharmacology 1997; 17: 323
   PubMed Web of Science ®Google Scholar
• Parker G, Malhi G. Are atypical antipsychotic drugs also atypical antidepressants?. Australian and New Zealand Journal of Psychiatry 2001; 35: 631–638
   PubMed Web of Science ®Google Scholar
• Stoll A L, Mayer P V, Kolbrener M, et al. Antidepressantassociated mania: a controlled comparison with spontaneous mania. American Journal of Psychiatry 1994; 151: 1642–1645
   PubMed Web of Science ®Google Scholar
• Debattista C, Schatzberg A F. Physical symptoms associated with paroxetine withdrawal. American Journal of Psychiatry 1995; 152: 1235–1236
   PubMed Web of Science ®Google Scholar
• Szabadi E. Fluvoxamine withdrawal syndrome. British Journal of Psychiatry 1992; 160: 283–284
   PubMed Web of Science ®Google Scholar
• Goldstein T R, Frye M A, Denicoff K D, et al. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications for bipolar disorder. Journal of Clinical Psychiatry 1999; 60: 563–567
   PubMed Web of Science ®Google Scholar
• Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A. Rapid cyclers and antidepressants. International Pharmacopsychiatry 1981; 16: 119–123
   PubMedGoogle Scholar
• Alschuler L L, Post R M, Leverich G S, Mikalauskas K, Rossoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. American Journal of Psychiatry 1995; 152: 1130–1138
   PubMed Web of Science ®Google Scholar
• Wehr T A, Goodwin F K. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Archives of General Psychiatry 1979; 36: 555–559
   PubMed Web of Science ®Google Scholar
• Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. British Journal of Psychiatry 1994; 164: 549–550
   PubMed Web of Science ®Google Scholar
• Ramasublin R. Dose–response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta Psychiatrica Scandinavica 2001; 104: 236–239
   PubMed Web of Science ®Google Scholar
• Settle E C, Settle G P. A case of mania associated with flouxetine. American Journal of Psychiatry 1984; 141: 280–281
   PubMed Web of Science ®Google Scholar
• Chouniard G, Steiner W. A case of mania induced by high-dose fluoxetine treatment. American Journal of Psychiatry 1986; 143: 686
   PubMed Web of Science ®Google Scholar
• Cooper G L. The safety of fluoxetine –an update. British Journal of Psychiatry 1988; 153: 77–86
   Web of Science ®Google Scholar
• Simpson S G, DePaulo J R. Fluoxetine treatment of bipolar II depression. Journal of Clinical Psychopharmacology 1991; 11: 52–54
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Rapport D J, Kimmel S E, Shelton M D. Controlled trials in bipolar I depression: focus on switch rates and efficacy. European Neuropsychopharmacology 1999; 9(Suppl. 4)S109–S112
   PubMed Web of Science ®Google Scholar
• Parker G. Do the newer antidepressants have mood stabilizing properties?. Australian and New Zealand Journal of Psychiatry 2001; 36: 427–428
   Web of Science ®Google Scholar
• Frances A J, Kahn D A, Carpenter D, Docherty J P, Donovan S L. The expert consensus guidelines for treating depression in bipolar disorder. Journal of Clinical Psychiatry 1998; 59(Suppl. 4)73–79
   PubMed Web of Science ®Google Scholar
• Goodwin F K, Jamison K R. Manic-depressive illness. Oxford University Press, New York 1990
   Google Scholar
• Vieta E, Martinez-Aran A, Goikolea J M, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. Journal of Clinical Psychiatry 2002; 63: 508–512
   PubMed Web of Science ®Google Scholar
• Amsterdam J. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. Journal of Clinical Psychopharmacology 1998; 18: 414–417
   PubMed Web of Science ®Google Scholar
• Montgomery S A. Safety of mirtazapine: a review. International Clinical Psychopharmacology 1995; 10(Suppl. 4)37–45
   PubMed Web of Science ®Google Scholar
• Nolen W A, Bloenholk D. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology 2000; 42(Suppl. 1)11–17
   PubMed Web of Science ®Google Scholar
• Mitchell P, Sengoz A. Phenotypic expression of melancholia contrasted for those with bipolar and unipolar courses. Melancholia: a disorder of movement and mood, G Parker, D Hadzi-Pavlovic. Cambridge University Press, New York 1996; 172–178
   Google Scholar
• Parker G. Is differential effectiveness of the newer and older antidepressants mediated by an age effect on the phenotypic expression of depression?. Acta Psychiatrica Scandinavica 2002; 106: 168–170
   PubMed Web of Science ®Google Scholar